2025 Regular SessionMaryland Legislature

HB1366: Health Insurance - Testing for Ovarian and Cervical Cancers - Required Coverage and Prohibited Cost Sharing

Legislative Summary

Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for an annual cervical smear or Pap test and for surveillance tests for ovarian cancer; and prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from imposing a copayment, coinsurance, or deductible requirement on coverage required under the Act.

Demographic Impact

Overall analysis of equity impact

90% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

2/7/2025
First Reading Health and Government Operations
House of Delegates
2/12/2025
Hearing 3/11 at 1:00 p.m.
House of Delegates
3/11/2025
Hearing canceled
House of Delegates
3/11/2025
Hearing 3/11 at 2:45 p.m.
House of Delegates
3/11/2025
Hearing canceled
House of Delegates
3/12/2025
Withdrawn by Sponsor
House of Delegates

Status Information

Current Status
Introduced(2/7/2025)
Chamber
House of Delegates

Documents

Introduced
Bill Text2/9/202589.7 KB
Vote Image
Vote Image1/1/197043.9 KB